Food for thought: The role of appetitive peptides in age-related cognitive decline

Ageing Research Reviews

Volumn 12, Issue 3, 2013, Pages 764-776

  Fadel, Jim R ^a   Jolivalt, Corinne G ^b   Reagan, Lawrence P ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Hippocampus; Insulin; Leptin; Orexin

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; OREXIN; PEPTIDE;

AGING; ALZHEIMER DISEASE; BODY COMPOSITION; BODY WEIGHT; CELLULAR DISTRIBUTION; COGNITION; COGNITIVE DEFECT; DEMENTIA; ENERGY BALANCE; FOOD INTAKE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; METABOLIC DISORDER; METABOLIC REGULATION; NARCOLEPSY; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SLEEP;

ALZHEIMER'S DISEASE; DEMENTIA; HIPPOCAMPUS; INSULIN; LEPTIN; OREXIN;

AGING; ALZHEIMER DISEASE; ANIMALS; APPETITE REGULATION; HIPPOCAMPUS; HUMANS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; NEURONAL PLASTICITY; NEUROPEPTIDES; PEPTIDES;

EID: 84881541527     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.01.009     Document Type: Review

References (223)

1. Abbott M.A., Wells D.G., Fallon J.R. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. The Journal of Neuroscience 1999, 19:7300-7308.
2. Akbari E., Motamedi F., Naghdi N., Noorbakhshnia M. The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task. Behavioural Brain Research 2008, 187:172-177.
3. Akbari E., Naghdi N., Motamedi F. Functional inactivation of orexin 1 receptors in CA1 region impairs acquisition, consolidation and retrieval in Morris water maze task. Behavioural Brain Research 2006, 173:47-52.
4. Ammoun S., Holmqvist T., Shariatmadari R., Oonk H.B., Detheux M., Parmentier M., Akerman K.E., Kukkonen J.P. Distinct recognition of OX1 and OX2 receptors by orexin peptides. Journal of Pharmacology and Experimental Therapeutics 2003, 305:507-514.
5. Avila J., Wandosell F., Hernandez F. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Review of Neurotherapeutics 2010, 10:703-710.
6. Baird J.P., Choe A., Loveland J.L., Beck J., Mahoney C.E., Lord J.S., Grigg L.A. Orexin-A hyperphagia: hindbrain participation in consummatory feeding responses. Endocrinology 2009, 150:1202-1216.
7. Baldo B.A., Daniel R.A., Berridge C.W., Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. Journal of Comparative Neurology 2003, 464:220-237.
8. Banks W.A. The many lives of leptin. Peptides 2004, 25:331-338.
9. Barrett-Connor E., Edelstein S., Corey-Bloom J., Wiederholt W. Weight loss precedes dementia in community-dwelling older adults. Journal of Nutrition, Health and Aging 1998, 2:113-114.
10. Barrett-Connor E., Edelstein S.L., Corey-Bloom J., Wiederholt W.C. Weight loss precedes dementia in community-dwelling older adults. Journal of the American Geriatrics Society 1996, 44:1147-1152.
11. Baskin D.G., Breininger J.F., Schwartz M.W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 1999, 48:828-833.
12. Baumgartner R.N., Waters D.L., Morley J.E., Patrick P., Montoya G.D., Garry P.J. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism: Clinical and Experimental 1999, 48:378-384.
13. Bayer-Carter J.L., Green P.S., Montine T.J., VanFossen B., Baker L.D., Watson G.S., Bonner L.M., Callaghan M., Leverenz J.B., Walter B.K., Tsai E., Plymate S.R., Postupna N., Wilkinson C.W., Zhang J., Lampe J., Kahn S.E., Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives in Neurology 2011, 68:743-752.
14. Benedict C., Brooks S.J., Kullberg J., Burgos J., Kempton M.J., Nordenskjold R., Nylander R., Kilander L., Craft S., Larsson E.M., Johansson L., Ahlstrom H., Lind L., Schioth H.B. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 2012, 35:488-494.
15. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurology 2008, 7:184-190.
16. Bigalke B., Schreitmuller B., Sopova K., Paul A., Stransky E., Gawaz M., Stellos K., Laske C. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. PLoS ONE 2011, 6:e20286.
17. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
18. Boschen K.E., Fadel J.R., Burk J.A. Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats. Psychopharmacology 2009, 206:205-213.
19. Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. The Journal of Neuroscience 2005, 25:2429-2433.
20. Burdakov D., Jensen L.T., Alexopoulos H., Williams R.H., Fearon I.M., O'Kelly I., Gerasimenko O., Fugger L., Verkhratsky A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006, 50:711-722.
21. Burdo J.R., Chen Q., Calcutt N.A., Schubert D. The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiology of Aging 2009, 30:1910-1917.
22. Cai X.J., Evans M.L., Lister C.A., Leslie R.A., Arch J.R., Wilson S., Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001, 50:105-112.
23. Cai X.J., Widdowson P.S., Harrold J., Wilson S., Buckingham R.E., Arch J.R., Tadayyon M., Clapham J.C., Wilding J., Williams G. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 1999, 48:2132-2137.
24. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
25. Chen S., Liu A.R., An F.M., Yao W.B., Gao X.D. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4. Age (Dordr) 2012, 34:1211-1224.
26. Chou T.C., Lee C.E., Lu J., Elmquist J.K., Hara J., Willie J.T., Beuckmann C.T., Chemelli R.M., Sakurai T., Yanagisawa M., Saper C.B., Scammell T.E. Orexin (hypocretin) neurons contain dynorphin. The Journal of Neuroscience 2001, 21:RC168.
27. Clark E.L., Baumann C.R., Cano G., Scammell T.E., Mochizuki T. Feeding-elicited cataplexy in orexin knockout mice. Neuroscience 2009, 161:970-977.
28. Craft S., Baker L.D., Montine T.J., Minoshima S., Watson G.S., Claxton A., Arbuckle M., Callaghan M., Tsai E., Plymate S.R., Green P.S., Leverenz J., Cross D., Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives in Neurology 2012, 69:29-38.
29. Craft S., Cholerton B., Baker L.D. Insulin and Alzheimer's disease: untangling the web. Journal of Alzheimer's Disease 2013, 33(Supl 1):S263-S275.
30. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
31. Currais A., Prior M., Lo D., Jolivalt C., Schubert D., Maher P. Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell 2012, 11:107-1026.
32. Dandona P., Mohamed I., Ghanim H., Sia C.L., Dhindsa S., Dandona S., Makdissi A., Chaudhuri A. Insulin suppresses the expression of amyloid precursor protein, presenilins, and glycogen synthase kinase-3beta in peripheral blood mononuclear cells. Journal of Clinical Endocrinology and Metabolism 2011, 96:1783-1788.
33. De Felice F.G., Vieira M.N., Bomfim T.R., Decker H., Velasco P.T., Lambert M.P., Viola K.L., Zhao W.Q., Ferreira S.T., Klein W.L. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1971-1976.
34. de la Monte S.M. Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Frontiers in Bioscience (Elite Edition) 2012, 4:1582-1605.
35. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2005, 7:45-61.
36. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:322-327.
37. de Lecea L., Sutcliffe J.G., Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002, 36:85-95.
38. Deadwyler S.A., Porrino L., Siegel J.M., Hampson R.E. Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. The Journal of Neuroscience 2007, 27:14239-14247.
39. Dineley K.T., Kayed R., Neugebauer V., Fu Y., Zhang W., Reese L.C., Taglialatela G. Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. Journal of Neuroscience Research 2010, 88:2923-2932.
40. Doherty G.H., Beccano-Kelly D., Yan S.D., Gunn-Moore F.J., Harvey J. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid beta. Neurobiology of Aging 2013, 34:226-237.
41. Dube M.G., Kalra S.P., Kalra P.S. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Research 1999, 842:473-477.
42. Duelli R., Schrock H., Kuschinsky W., Hoyer S. Intracerebroventricular injections of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. International Journal of Developmental Neuroscience 1994, 12:737-743.
43. Durakoglugil M., Irving A.J., Harvey J. Leptin induces a novel form of NMDA receptor-dependent long-term depression. Journal of Neurochemistry 2005, 95:396-405.
44. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. Journal of Comparative Neurology 1998, 395:535-547.
45. Espana R.A., Reis K.M., Valentino R.J., Berridge C.W. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. Journal of Comparative Neurology 2005, 481:160-178.
46. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
47. Fadel J., Pasumarthi R., Reznikov L. Stimulation of cortical acetylcholine release by orexin A. Neuroscience 2005, 130:541-547.
48. Farr S.A., Banks W.A., Morley J.E. Effects of leptin on memory processing. Peptides 2006, 27:1420-1425.
49. Fernandez-Galaz C., Fernandez-Agullo T., Campoy F., Arribas C., Gallardo N., Andres A., Ros M., Carrascosa J.M. Decreased leptin uptake in hypothalamic nuclei with ageing in Wistar rats. Journal of Endocrinology 2001, 171:23-32.
50. Fewlass D.C., Noboa K., Pi-Sunyer F.X., Johnston J.M., Yan S.D., Tezapsidis N. Obesity-related leptin regulates Alzheimer's A beta. FASEB Journal 2004, 18:1870-1878.
51. Figlewicz D.P., Benoit S.C. Insulin, leptin, and food reward: update 2008. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2009, 296:R9-R19.
52. Figlewicz D.P., MacDonald N.A., Sipols A.J. Modulation of food reward by adiposity signals. Physiology and Behavior 2007, 91:473-478.
53. Forlenza O.V., Diniz B.S., Radanovic M., Santos F.S., Talib L.L., Gattaz W.F. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. British Journal of Psychiatry 2011, 198:351-356.
54. Francis G.J., Martinez J.A., Liu W.Q., Xu K., Ayer A., Fine J., Tuor U.I., Glazner G., Hanson L.R., Frey W.H., Toth C. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain 2008, 131:3311-3334.
55. Frederick-Duus D., Guyton M.F., Fadel J. Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 2007, 149:499-507.
56. Fronczek R., Overeem S., Lee S.Y., Hegeman I.M., van Pelt J., van Duinen S.G., Lammers G.J., Swaab D.F. Hypocretin (orexin) loss and sleep disturbances in Parkinson's disease. Brain 2008, 131:e88.
57. Fronczek R., van Geest S., Frolich M., Overeem S., Roelandse F.W., Lammers G.J., Swaab D.F. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiology of Aging 2012, 33:1642-1650.
58. Fujiki N., Yoshida Y., Zhang S., Sakurai T., Yanagisawa M., Nishino S. Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides 2006, 27:2326-2331.
59. Gao C., Holscher C., Liu Y., Li L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Reviews in the Neurosciences 2012, 23:1-11.
60. Garza J.C., Guo M., Zhang W., Lu X.Y. Leptin promotes adult hippocampal neurogenesis in vivo and in vitro. Journal of Biological Chemistry 2008, 283:18238-18247.
61. Gault V.A., Porter W.D., Flatt P.R., Holscher C. Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. International Journal of Obesity (London) 2010, 34:1341-1344.
62. Gengler S., McClean P.L., McCurtin R., Gault V.A., Holscher C. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiology of Aging 2012, 33:265-276.
63. Gerashchenko D., Salin-Pascual R., Shiromani P.J. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta. Brain Research 2001, 913:106-115.
64. Gerges N.Z., Aleisa A.M., Alkadhi K.A. Impaired long-term potentiation in obese zucker rats: possible involvement of presynaptic mechanism. Neuroscience 2003, 120:535-539.
65. Graff J., Koshibu K., Jouvenceau A., Dutar P., Mansuy I.M. Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity. Learning and Memory 2010, 17:355-363.
66. Greco S.J., Bryan K.J., Sarkar S., Zhu X., Smith M.A., Ashford J.W., Johnston J.M., Tezapsidis N., Casadesus G. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 2010, 19:1155-1167.
67. Greco S.J., Sarkar S., Johnston J.M., Tezapsidis N. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochemical and Biophysical Research Communications 2009, 380:98-104.
68. Grillo C.A., Piroli G.G., Hendry R.M., Reagan L.P. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Research 2009, 1296:35-45.
69. Gunstad J., Spitznagel M.B., Keary T.A., Glickman E., Alexander T., Karrer J., Stanek K., Reese L., Juvancic-Heltzel J. Serum leptin levels are associated with cognitive function in older adults. Brain Research 2008, 1230:233-236.
70. Hakansson M., de Lecea L., Sutcliffe J.G., Yanagisawa M., Meister B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. Journal of Neuroendocrinology 1999, 11:653-663.
71. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
72. Harris G.C., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends in the Neurological Sciences 2006, 29:571-577.
73. Harvey J. Leptin: the missing link in Alzheimer disease?. Clinical Chemistry 2010, 56:696-697.
74. Havrankova J., Brownstein M., Roth J. Insulin and insulin receptors in rodent brain. Diabetologia 1981, 20(Suppl.):268-273.
75. Havrankova J., Roth J., Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272:827-829.
76. Havrankova J., Roth J., Brownstein M.J. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. Journal of Clinical Investigation 1979, 64:636-642.
77. Haynes A.C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R.A., Arch J.R. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regulatory Peptides 2000, 96:45-51.
78. Haynes A.C., Jackson B., Overend P., Buckingham R.E., Wilson S., Tadayyon M., Arch J.R. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999, 20:1099-1105.
79. Henny P., Brischoux F., Mainville L., Stroh T., Jones B.E. Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience 2010, 169:1150-1157.
80. Hill J.M., Lesniak M.A., Pert C.B., Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 1986, 17:1127-1138.
81. Ho L., Qin W., Pompl P.N., Xiang Z., Wang J., Zhao Z., Peng Y., Cambareri G., Rocher A., Mobbs C.V., Hof P.R., Pasinetti G.M. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB Journal 2004, 18:902-904.
82. Holden K.F., Lindquist K., Tylavsky F.A., Rosano C., Harris T.B., Yaffe K. Serum leptin level and cognition in the elderly: findings from the Health ABC Study. Neurobiology of Aging 2009, 30:1483-1489.
83. Hosoi T., Okuma Y., Ono A., Nomura Y. Alteration of leptin-induced STAT3 activation in the brain of senescence-accelerated mouse (SAM) P8. Biological and Pharmaceutical Bulletin 2005, 28:1514-1516.
84. Huang C.C., Lee C.C., Hsu K.S. An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus. Journal of Neurochemistry 2004, 89:217-231.
85. Huang C.C., You J.L., Lee C.C., Hsu K.S. Insulin induces a novel form of postsynaptic mossy fiber long-term depression in the hippocampus. Molecular and Cellular Neurosciences 2003, 24:831-841.
86. Huang H., Ghosh P., van den Pol A.N. Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. Journal of Neurophysiology 2006, 95:1656-1668.
87. Isacson R., Nielsen E., Dannaeus K., Bertilsson G., Patrone C., Zachrisson O., Wikstrom L. The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. European Journal of Pharmacology 2011, 650:249-255.
88. Isidori A.M., Strollo F., More M., Caprio M., Aversa A., Moretti C., Frajese G., Riondino G., Fabbri A. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. Journal of Clinical Endocrinology and Metabolism 2000, 85:1954-1962.
89. Jo J., Whitcomb D.J., Olsen K.M., Kerrigan T.L., Lo S.C., Bru-Mercier G., Dickinson B., Scullion S., Sheng M., Collingridge G., Cho K. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nature Neuroscience 2011, 14:545-547.
90. Johnson D.K., Wilkins C.H., Morris J.C. Accelerated weight loss may precede diagnosis in Alzheimer disease. Archives in Neurology 2006, 63:1312-1317.
91. Jolivalt C.G., Fineman M., Deacon C.F., Carr R.D., Calcutt N.A. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes, Obesity and Metabolism 2011, 13:990-1000.
92. Jolivalt C.G., Hurford R., Lee C.A., Dumaop W., Rockenstein E., Masliah E. Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Experimental Neurology 2010, 223:422-431.
93. Jolivalt C.G., Lee C.A., Beiswenger K.K., Smith J.L., Orlov M., Torrance M.A., Masliah E. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin. Journal of Neuroscience Research 2008, 86:3265-3274.
94. 2+ pool and of neuropeptide secretion. Nature 1997, 385:343-346.
95. Karteris E., Machado R.J., Chen J., Zervou S., Hillhouse E.W., Randeva H.S. Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. American Journal of Physiology. Endocrinology and Metabolism 2005, 288:E1089-E1100.
96. Ke Y.D., Delerue F., Gladbach A., Gotz J., Ittner L.M. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE 2009, 4:e7917.
97. Kessler B.A., Stanley E.M., Frederick-Duus D., Fadel J. Age-related loss of orexin/hypocretin neurons. Neuroscience 2011, 178:82-88.
98. King M.R., Anderson N.J., Guernsey L.S., Jolivalt C.G. Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. Journal of Neuroscience Research 2013, 91:506-514.
99. Kirouac G.J., Parsons M.P., Li S. Orexin (hypocretin) innervation of the paraventricular nucleus of the thalamus. Brain Research 2005, 1059:179-188.
100. Knittweis J. Weight loss precedes Alzheimer's disease symptoms: a case study. Journal of the American Geriatrics Society 1998, 46:540-541.
101. Kotz C.M., Mullett M.A., Wang C. Diminished feeding responsiveness to orexin A (hypocretin 1) in aged rats is accompanied by decreased neuronal activation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2005, 289:R359-R366.
102. Labad J., Price J.F., Strachan M.W., Deary I.J., Seckl J.R., Sattar N., Reynolds R.M. Serum leptin and cognitive function in people with type 2 diabetes. Neurobiology of Aging 2012, 33:2938-2941.
103. Lambe E.K., Olausson P., Horst N.K., Taylor J.R., Aghajanian G.K. Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat. The Journal of Neuroscience 2005, 25:5225-5229.
104. Lammers G.J., Pijl H., Iestra J., Langius J.A., Buunk G., Meinders A.E. Spontaneous food choice in narcolepsy. Sleep 1996, 19:75-76.
105. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adults rats. Behavioral Neuroscience 1998, 112:1199-1208.
106. Lee C.C., Huang C.C., Hsu K.S. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 2011, 61:867-879.
107. Lee C.C., Huang C.C., Wu M.Y., Hsu K.S. Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. Journal of Biological Chemistry 2005, 280:18543-18550.
108. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. American Journal of Epidemiology 1997, 145:301-308.
109. Leinninger G.M., Jo Y.H., Leshan R.L., Louis G.W., Yang H., Barrera J.G., Wilson H., Opland D.M., Faouzi M.A., Gong Y., Jones J.C., Rhodes C.J., Chua S., Diano S., Horvath T.L., Seeley R.J., Becker J.B., Munzberg H., Myers M.G. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metabolism 2009, 10:89-98.
110. Leinninger G.M., Opland D.M., Jo Y.H., Faouzi M., Christensen L., Cappellucci L.A., Rhodes C.J., Gnegy M.E., Becker J.B., Pothos E.N., Seasholtz A.F., Thompson R.C., Myers M.G. Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance. Cell Metabolism 2011, 14:313-323.
111. Lester-Coll N., Rivera E.J., Soscia S.J., Doiron K., Wands J.R., de la Monte S.M. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. Journal of Alzheimer's Disease 2006, 9:13-33.
112. Levin B.E., Dunn-Meynell A.A., Banks W.A. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2004, 286:R143-R150.
113. Li J., Deng J., Sheng W., Zuo Z. Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice. Pharmacology Biochemistry and Behavior 2012, 101:564-574.
114. Li L., Zhang Z.F., Holscher C., Gao C., Jiang Y.H., Liu Y.Z. (Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. European Journal of Pharmacology 2012, 674:280-286.
115. Li X.L., Aou S., Oomura Y., Hori N., Fukunaga K., Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 2002, 113:607-615.
116. Lieb W., Beiser A.S., Vasan R.S., Tan Z.S., Au R., Harris T.B., Roubenoff R., Auerbach S., Decarli C., Wolf P.A., Seshadri S. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. Journal of the American Medical Society 2009, 302:2565-2572.
117. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
118. Liu L., Brown J.C., Webster W.W., Morrisett R.A., Monaghan D.T. Insulin potentiates N-methyl-d-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neuroscience Letters 1995, 192:5-8.
119. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. Journal of Pathology 2011, 225:54-62.
120. London E.D., Berman S.M., Chakrapani S., Delibasi T., Monterosso J., Erol H.K., Paz-Filho G., Wong M.L., Licinio J. Short-term plasticity of gray matter associated with leptin deficiency and replacement. Journal of Clinical Endocrinology and Metabolism 2011, 96:E1212-E1220.
121. Louis G.W., Leinninger G.M., Rhodes C.J., Myers M.G. Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons. The Journal of Neuroscience 2010, 30:11278-11287.
122. Lu X.Y., Bagnol D., Burke S., Akil H., Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Hormones and Behavior 2000, 37:335-344.
123. Manschot S.M., Brands A.M., van der G.J., Kessels R.P., Algra A., Kappelle L.J., Biessels G.J. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006, 55:1106-1113.
124. Marwarha G., Prasanthi J.R., Schommer J., Dasari B., Ghribi O. Molecular interplay between leptin, insulin-like growth factor-1, and beta-amyloid in organotypic slices from rabbit hippocampus. Molecular Neurodegeneration 2011, 6:41.
125. Matochik J.A., London E.D., Yildiz B.O., Ozata M., Caglayan S., Depaoli A.M., Wong M.L., Licinio J. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. Journal of Clinical Endocrinology and Metabolism 2005, 90:2851-2854.
126. McCarthy A.M., Lindgren S., Mengeling M.A., Tsalikian E., Engvall J.C. Effects of diabetes on learning in children. Pediatrics 2002, 109:E9.
127. McClean P.L., Gault V.A., Harriott P., Holscher C. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. European Journal of Pharmacology 2010, 630:158-162.
128. McClean P.L., Parthsarathy V., Faivre E., Holscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. The Journal of Neuroscience 2011, 31:6587-6594.
129. Mieda M., Williams S.C., Sinton C.M., Richardson J.A., Sakurai T., Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. The Journal of Neuroscience 2004, 24:10493-10501.
130. Moriguchi T., Sakurai T., Nambu T., Yanagisawa M., Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neuroscience Letters 1999, 264:101-104.
131. Morrison C.D. Leptin signaling in brain: a link between nutrition and cognition?. Biochimica et Biophysica Acta 2009, 1792:401-408.
132. Moult P.R., Cross A., Santos S.D., Carvalho A.L., Lindsay Y., Connolly C.N., Irving A.J., Leslie N.R., Harvey J. Leptin regulates AMPA receptor trafficking via PTEN inhibition. The Journal of Neuroscience 2010, 30:4088-4101.
133. Moult P.R., Harvey J. Regulation of glutamate receptor trafficking by leptin. Biochemical Society Transactions 2009, 37:1364-1368.
134. Moult P.R., Harvey J. NMDA receptor subunit composition determines the polarity of leptin-induced synaptic plasticity. Neuropharmacology 2011, 61:924-936.
135. Moult P.R., Milojkovic B., Harvey J. Leptin reverses long-term potentiation at hippocampal CA1 synapses. Journal of Neurochemistry 2009, 108:685-696.
136. Munzberg H., Myers M.G. Molecular and anatomical determinants of central leptin resistance. Nature Neuroscience 2005, 8:566-570.
137. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology and Metabolism 2010, 21:643-651.
138. Nadebaum C., Scratch S.E., Northam E.A., Cameron F.J. Clinical utility of mental state screening as a predictor of intellectual outcomes 6 months after diagnosis of type 1 diabetes. Pediatric Diabetes 2012, 13:632-637.
139. Narita K., Kosaka H., Okazawa H., Murata T., Wada Y. Relationship between plasma leptin level and brain structure in elderly: a voxel-based morphometric study. Biological Psychiatry 2009, 65:992-994.
140. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. The Lancet 2000, 355:39-40.
141. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., Okun M., Rogers W., Brooks S., Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Annals of Neurology 2001, 50:381-388.
142. Nistico R., Cavallucci V., Piccinin S., Macri S., Pignatelli M., Mehdawy B., Blandini F., Laviola G., Lauro D., Mercuri N.B., D'Amelio M. Insulin receptor beta-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromolecular Medicine 2012, 14:262-269.
143. O'Malley D., MacDonald N., Mizielinska S., Connolly C.N., Irving A.J., Harvey J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Molecular and Cellular Neurosciences 2007, 35:559-572.
144. Oomura Y., Hori N., Shiraishi T., Fukunaga K., Takeda H., Tsuji M., Matsumiya T., Ishibashi M., Aou S., Li X.L., Kohno D., Uramura K., Sougawa H., Yada T., Wayner M.J., Sasaki K. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006, 27:2738-2749.
145. Ostlund R.E., Yang J.W., Klein S., Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. Journal of Clinical Endocrinology and Metabolism 1996, 81:3909-3913.
146. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996, 39:1392-1397.
147. Paz-Filho G.J., Babikian T., Asarnow R., Delibasi T., Esposito K., Erol H.K., Wong M.L., Licinio J. Leptin replacement improves cognitive development. PLoS ONE 2008, 3:e3098.
148. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002, 51:1256-1262.
149. Perello M., Sakata I., Birnbaum S., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., Woloszyn J., Yanagisawa M., Lutter M., Zigman J.M. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biological Psychiatry 2010, 67:880-886.
150. Perez-Gonzalez R., Antequera D., Vargas T., Spuch C., Bolos M., Carro E. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease 2011, 24(Suppl. 2):17-25.
151. Perry H.M., Morley J.E., Horowitz M., Kaiser F.E., Miller D.K., Wittert G. Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metabolism: Clinical and Experimental 1997, 46:1399-1405.
152. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. The Journal of Neuroscience 1998, 18:9996-10015.
153. Pintana H., Apaijai N., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sciences 2012, 91:409-414.
154. Plaschke K., Hoyer S. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. International Journal of Developmental Neuroscience 1993, 11:477-483.
155. Plaschke K., Kopitz J., Siegelin M., Schliebs R., Salkovic-Petrisic M., Riederer P., Hoyer S. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. Journal of Alzheimer's Disease 2010, 19:691-704.
156. Ponce-Lopez T., Liy-Salmeron G., Hong E., Meneses A. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3beta decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. Brain Research 2011, 1426:73-85.
157. Porkka-Heiskanen T., Alanko L., Kalinchuk A., Heiskanen S., Stenberg D. The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain. Neurobiology of Aging 2004, 25:231-238.
158. Porter D., Faivre E., Flatt P.R., Holscher C., Gault V.A. Actions of incretin metabolites on locomotor activity, cognitive function and in vivo hippocampal synaptic plasticity in high fat fed mice. Peptides 2012, 35:1-8.
159. Porter D.W., Kerr B.D., Flatt P.R., Holscher C., Gault V.A. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes, Obesity and Metabolism 2010, 12:891-899.
160. Power D.A., Noel J., Collins R., O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dementia and Geriatric Cognitive Disorders 2001, 12:167-170.
161. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990, 13:16-21.
162. Reilly C.E. I. Mutation in the hypocretin (orexin) receptor 2 gene causes canine narcolepsy. Journal of Neurology 1999, 246:985-986.
163. Revill P., Moral M.A., Prous J.R. Impaired insulin signaling and the pathogenesis of Alzheimer's disease. Drugs Today (Barcelona) 2006, 42:785-790.
164. Rieger M., Mayer G., Gauggel S. Attention deficits in patients with narcolepsy. Sleep 2003, 26:36-43.
165. Rodgers R.J., Ishii Y., Halford J.C., Blundell J.E. Orexins and appetite regulation. Neuropeptides 2002, 36:303-325.
166. Ronnemaa E., Zethelius B., Sundelof J., Sundstrom J., Degerman-Gunnarsson M., Lannfelt L., Berne C., Kilander L. Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. Diabetologia 2009, 52:1504-1510.
167. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., Leibel R.L. Effects of gender, body composition, and menopause on plasma concentrations of leptin. Journal of Clinical Endocrinology and Metabolism 1996, 81:3424-3427.
168. Rosin D.L., Weston M.C., Sevigny C.P., Stornetta R.L., Guyenet P.G. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. Journal of Comparative Neurology 2003, 465:593-603.
169. Rovet J.F., Ehrlich R.M., Hoppe M. Intellectual deficits associated with early onset of insulin-dependent diabetes mellitus in children. Diabetes Care 1987, 10:510-515.
170. Ryan C., Vega A., Drash A. Cognitive deficits in aldolescents who developed diabetes early in life. Pediatrics 1985, 75:921-927.
171. Ryan C.M., Williams T.M. Effects of insulin-dependent diabetes on learning and memory efficiency in adults. Journal of Clinical and Experimental Neuropsychology 1993, 15:685-700.
172. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
173. Santos T.D., Mazucanti C.H., Xavier G.F., Torrao A.D. Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin. Physiology and Behavior 2012, 107:401-413.
174. Sawai N., Ueta Y., Nakazato M., Ozawa H. Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus. Neuroscience Letters 2010, 468:51-55.
175. Scammell T.E., Winrow C.J. Orexin receptors: pharmacology and therapeutic opportunities. Annual Review of Pharmacology and Toxicology 2011, 51:243-266.
176. Scarpace P.J., Matheny M., Moore R.L., Tumer N. Impaired leptin responsiveness in aged rats. Diabetes 2000, 49:431-435.
177. Scarpace P.J., Matheny M., Shek E.W. Impaired leptin signal transduction with age-related obesity. Neuropharmacology 2000, 39:1872-1879.
178. Scarpace P.J., Matheny M., Tumer N. Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 2001, 104:1111-1117.
179. Schulz C., Paulus K., Lehnert H. Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 2004, 145:2696-2701.
180. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D. Insulin in the brain: a hormonal regulator of energy balance. Endocrinology Reviews 1992, 13:387-414.
181. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
182. Selbach O., Bohla C., Barbara A., Doreulee N., Eriksson K.S., Sergeeva O.A., Haas H.L. Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases. Acta Physiologica (Oxford) 2010, 198:277-285.
183. Selbach O., Doreulee N., Bohla C., Eriksson K.S., Sergeeva O.A., Poelchen W., Brown R.E., Haas H.L. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 2004, 127:519-528.
184. Sellayah D., Bharaj P., Sikder D. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metabolism 2011, 14:478-490.
185. Shanley L.J., Irving A.J., Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. Journal of Neuroscience 2001, 21. art-RC186.
186. Shek E.W., Scarpace P.J. Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regulatory Peptides 2000, 92:65-71.
187. Shemesh E., Rudich A., Harman-Boehm I., Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. Journal of Clinical Endocrinology and Metabolism 2012, 97:366-376.
188. Shingo A.S., Kanabayashi T., Murase T., Kito S. Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behavioural Brain Research 2012, 229:378-383.
189. Siegel J.M. Narcolepsy: a key role for hypocretins (orexins). Cell 1999, 98:409-412.
190. Smart D., Jerman J. The physiology and pharmacology of the orexins. Pharmacology & Therapeutics 2002, 94:51-61.
191. Stanley E.M., Fadel J. Aging-related deficits in orexin/hypocretin modulation of the septohippocampal cholinergic system. Synapse 2012, 66:445-452.
192. Stanley E.M., Fadel J.R., Mott D.D. Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats. Neurobiology of Aging 2011, 33:431.e1-431.e13.
193. Stanley E.M., Wilson M.A., Fadel J.R. Hippocampal neurotransmitter efflux during one-trial novel object recognition in rats. Neuroscience Letters 2012, 511:38-42.
194. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?. Journal of Alzheimer's Disease 2005, 7:63-80.
195. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nature Neuroscience 2008, 11:309-317.
196. Stranahan A.M., Lee K., Martin B., Maudsley S., Golden E., Cutler R.G., Mattson M.P. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
197. Sweet D.C., Levine A.S., Billington C.J., Kotz C.M. Feeding response to central orexins. Brain Research 1999, 821:535-538.
198. Taghibiglou C., Bradley C.A., Gaertner T., Li Y., Wang Y., Wang Y.T. Mechanisms involved in cholesterol-induced neuronal insulin resistance. Neuropharmacology 2009, 57:268-276.
199. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., Morishita R. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7036-7041.
200. Takeda S., Sato N., Uchio-Yamada K., Yu H., Moriguchi A., Rakugi H., Morishita R. Oral glucose loading modulates plasma beta-amyloid Level in Alzheimer's disease patients: potential diagnostic method for Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2012, 34:25-30.
201. Talbot K., Wang H.Y., Kazi H., Han L.Y., Bakshi K.P., Stucky A., Fuino R.L., Kawaguchi K.R., Samoyedny A.J., Wilson R.S., Arvanitakis Z., Schneider J.A., Wolf B.A., Bennett D.A., Trojanowski J.Q., Arnold S.E. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. Journal of Clinical Investigation 2012, 122:1316-1338.
202. Terao A., Apte-Deshpande A., Morairty S., Freund Y.R., Kilduff T.S. Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain. Neuroscience Letters 2002, 332:190-194.
203. Thannickal T.C., Lai Y.Y., Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007, 130:1586-1595.
204. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
205. Torrealba F., Yanagisawa M., Saper C.B. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003, 119:1033-1044.
206. Tsuneki H., Murata S., Anzawa Y., Soeda Y., Tokai E., Wada T., Kimura I., Yanagisawa M., Sakurai T., Sasaoka T. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 2008, 51:657-667.
207. Tupone D., Madden C.J., Cano G., Morrison S.F. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. The Journal of Neuroscience 2011, 31:15944-15955.
208. Unger J., McNeill T.H., Moxley R.T., White M., Moss A., Livingston J.N. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989, 31:143-157.
209. van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. The Journal of Neuroscience 1999, 19:3171-3182.
210. Velayudhan L., Poppe M., Archer N., Proitsi P., Brown R.G., Lovestone S. Risk of developing dementia in people with diabetes and mild cognitive impairment. British Journal of Psychiatry 2010, 196:36-40.
211. Waldrop M.A., Leinung M.C., Lee D.W., Grasso P. Intranasal delivery of mouse [d-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, improves energy balance, glycaemic control, insulin sensitivity and bone formation in leptin-resistant C57BLK/6-m db/db mice. Diabetes, Obesity and Metabolism 2010, 12:871-875.
212. Wan Q., Xiong Z.G., Man H.Y., Ackerley C.A., Braunton J., Lu W.Y., Becker L.E., MacDonald J.F., Wang Y.T. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 1997, 388:686-690.
213. Wang Z.W., Pan W.T., Lee Y., Kakuma T., Zhou Y.T., Unger R.H. The role of leptin resistance in the lipid abnormalities of aging. FASEB Journal 2001, 15:108-114.
214. Wayner M.J., Armstrong D.L., Phelix C.F., Oomura Y. Orexin-A (hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 2004, 25:991-996.
215. Winocur G., Greenwood C.E., Piroli G.G., Grillo C.A., Reznikov L.R., Reagan L.P., McEwen B.S. Memory impairment in obese zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behavioral Neuroscience 2005, 119:1389-1395.
216. Wrighten S.A., Piroli G.G., Grillo C.A., Reagan L.P. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochimica et Biophysica Acta 2008, 1792:44-453.
217. Xu W.L., von Strauss E., Qiu C.X., Winblad B., Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009, 52:1031-1039.
218. Yaffe K., Falvey C., Hamilton N., Schwartz A.V., Simonsick E.M., Satterfield S., Cauley J.A., Rosano C., Launer L.J., Strotmeyer E.S., Harris T.B. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Archives in Neurology 2012, 69:1170-1175.
219. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
220. Yang Y., Ma D., Wang Y., Jiang T., Hu S., Zhang M., Yu X., Gong C.X. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. Journal of Alzheimer's Disease 2013, 33:329-338.
221. Yau P.L., Castro M.G., Tagani A., Tsui W.H., Convit A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics 2012, 130:e856-e864.
222. Zeki A.H., Stone K.L., Haan M.N., Yaffe K. Leptin, mild cognitive impairment, and dementia among elderly women. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2012, 68:175-180.
223. Zhang X., Heng X., Li T., Li L., Yang D., Zhang X., Du Y., Doody R.S., Le W. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model. Journal of Alzheimer's Disease 2011, 24:739-749.